Acytinib side effects include hypertension, arterial and venous thromboembolism, and bleeding. Axitinib inhibits pathological angiogenesis, tumor growth, and cancer progression by inhibiting tyrosine kinase receptors. It is indicated for the treatment of partially eligible adult patients with renal cell carcinoma. Common side effects of this drug include hypertension, arteriovenous thromboembolism, bleeding, heart failure, gastrointestinal perforation, proteinuria, hepatic impairment, diarrhea, and fatigue. The occurrence of side effects varies from person to person. The above side effects can be life-threatening in severe cases, and the drug should be used under the direction of a physician. This drug is contraindicated in people who are allergic to it. If any adverse reaction occurs after the use of this drug, the drug should be stopped and medical treatment should be sought.